Bank of America’s Virpax Pharmaceuticals, Inc. Common Stock VRPX Stock Holding History

Bank of America’s Portfolio VRPX Stock Details VRPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5	Closed	-$6	–	8808
2025 Q1	$6	Buy	5 +2	+67%	+$12	﹤0.01%	8235
2024 Q4	$25	Buy	3 +2	+200%	+$27	﹤0.01%	7992
2024 Q3	$26	Buy	+1	New	+$25	﹤0.01%	7933
2024 Q2	–	Hold	0	–	–	–	8142

Other funds holding VRPX

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Bank of America's VRPX Position: Q2 2025 in Review

Bank of America sold out of Virpax Pharmaceuticals, Inc. Common Stock (VRPX) in Q2 2025, closing a stake of 5 shares — an estimated $6 sold.

Bank of America first reported a position in VRPX in Q3 2024 and held it in 3 quarters. The position peaked at $26 in Q3 2024. 1 fund tracked by Wall St. Rank holds VRPX as of Q2 2025.

Bank of America reported no remaining Virpax Pharmaceuticals, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
Bank of America sold 5 Virpax Pharmaceuticals, Inc. Common Stock shares in Q2 2025, an estimated $6.
Bank of America first reported a position in Virpax Pharmaceuticals, Inc. Common Stock in Q3 2024 and held it in 3 quarters.
Bank of America's Virpax Pharmaceuticals, Inc. Common Stock position peaked at $26 in Q3 2024.
1 fund tracked by Wall St. Rank held Virpax Pharmaceuticals, Inc. Common Stock as of Q2 2025.

Based on Bank of America's 13F filing for Q2 2025, filed 14 Aug 2025.